UNSPSC 51342707: Interferon alfacon-1

This classification denotes an interferon, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 56588OP40D. European Medicines Agency schedules Interferon alfa-2a in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08199MIG. As of Q4 2014, INTERFERON ALFACON-1 remains the US FDA Preferred Term for this commodity. Interferon alfacon-1 bears US NLM identifiers UMLS ID C0164613 and NCI Concept Code C1766. SMILES: NONE.

UNSPSC 51342707 Interferon alfacon-1 is a Commodity code for a specific antiviral pharmaceutical product, but the recent state and local opportunities tagged under this code do not reflect procurement of interferon alfacon-1 itself. Instead, the opportunities show state and local health agencies buying other pharmaceutical products — antibiotics, opioid-reversal agents, and drug deactivation systems — through piggyback cooperative purchasing agreements and competitive bidding processes. The scope of work under recent solicitations centers on emergency preparedness and community health supplies sourced through established pharmaceutical warehousing and distribution contracts. Issuing bodies include state health departments and county health authorities managing procurement for public health programs and emergency response readiness.

Illinois Department of Public Health awarded a pharmaceutical warehouse piggyback contract through the MMCAP Infuse consortium to Chartwell Rx LLC on August 28, 2026 for Doxycycline Hyclate 100mg and Ciprofloxacin Hydrochloride 500mg tablets, with a total award of $2,999,999.11 over 12 months plus two one-year renewal options. Separately, Seminole County, Florida released an Invitation for Bid on June 30, 2026 (IFB 60459723LAS, response deadline July 26, 2026) for 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually, with quarterly deliveries to the Seminole County Community Health Building in Sanford. Recent activity is concentrated in Florida and Illinois, though the mismatch between the code's nominal scope and the actual products being solicited suggests this code carries limited relevance for state and local interferon alfacon-1 procurement specifically.